On one hand, enhancer of zeste homologue 2 (EZH2) and lysine 27 on histone H3 (H3K27) methyltransferase (H3K27me) highly mutate in GBM tumor cells, and lead to a poor outcome of GBM (96). The gene discussed is EZH2; the disease is neoplasm.